Oread Rx

About
Newsroom
Contact

Filter By Industry

Filter By Tag

Newsroom

Oread Rx Press releases

1 - 1 of 1 Press Release

Cost Plus Drugs and Oread Rx to Launch OTULFI™, an Affordable STELARA® Biosimilar, in April 2025

Apr 21, 2025

Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), and Oread Rx, LLC, announce a relationship to supply OTULFI™, a biosimilar of STELARA® to customers in April 2025.